Wecome Pharmaceutical Co Ltd Strategic Asset Allocation Index
Wecome Pharmaceutical Co Ltd strategic asset allocation index. Wecome Pharmaceutical Co Ltd (300878) has a Strategic Asset Allocation Index of 65.3% as of June 2023. Strategic assets (PP&E of CN¥964.33 Million plus long-term investments of CN¥-) total CN¥964.33 Million, measured against net assets of CN¥1.48 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Wecome Pharmaceutical Co Ltd (300878) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Wecome Pharmaceutical Co Ltd (2016–2022)
Strategic asset allocation index of Wecome Pharmaceutical Co Ltd from 2016 to 2022. This chart shows how Wecome Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 65.3%, representing strategic assets of CN¥964.33 Million against net assets of CN¥1.48 Billion CNY. Check 300878 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Wecome Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2016–2022)
Wecome Pharmaceutical Co Ltd strategic asset allocation index by year from 2016 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Wecome Pharmaceutical Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Wecome Pharmaceutical Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 63.4% | CN¥895.52 Million | CN¥895.52 Million | CN¥- | CN¥1.41 Billion | ▲ +13.3 pp |
| 2021 | 50.1% | CN¥706.09 Million | CN¥706.09 Million | CN¥- | CN¥1.41 Billion | ▲ +10.5 pp |
| 2020 | 39.7% | CN¥548.95 Million | CN¥548.95 Million | CN¥- | CN¥1.38 Billion | ▼ -31.3 pp |
| 2019 | 71.0% | CN¥368.94 Million | CN¥368.94 Million | CN¥- | CN¥519.84 Million | ▲ +8.5 pp |
| 2018 | 62.4% | CN¥245.94 Million | CN¥245.94 Million | CN¥- | CN¥393.83 Million | ▲ +21.4 pp |
| 2017 | 41.1% | CN¥125.71 Million | CN¥125.71 Million | CN¥- | CN¥306.05 Million | ▼ -4.0 pp |
| 2016 | 45.1% | CN¥95.03 Million | CN¥95.03 Million | CN¥- | CN¥210.90 Million | — |